This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hong Kong Baptist University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Guoqing Chen: Innovator in Anti-Cancer Research
Introduction
Guoqing Chen is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions. His work focuses on combining various compounds to enhance the efficacy of anti-cancer therapies.
Latest Patents
Guoqing Chen holds a patent for an "Anti-cancer composition consisting of halofuginone and sesquiterpene lactone compounds of artemisia apiacea and use thereof." This patent describes a combined pharmaceutical composition that includes halofuginone (HF) and sesquiterpene lactone compounds for treating cancers. The active ingredients in this composition exhibit a significant synergistic effect, making the combined pharmaceutical composition comparable or even superior to the widely used anti-cancer drug 5-FU. He has 1 patent to his name.
Career Highlights
Guoqing Chen is affiliated with Hong Kong Baptist University, where he conducts his research and collaborates with other experts in the field. His work has garnered attention for its potential to improve cancer treatment outcomes.
Collaborations
Some of his notable coworkers include Zhaoxiang Bian and Ruihong Gong, who contribute to the research efforts at Hong Kong Baptist University.
Conclusion
Guoqing Chen's innovative work in developing anti-cancer compositions showcases his commitment to advancing medical science. His contributions have the potential to significantly impact cancer treatment and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile